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Abstract
It is known in humans and mouse models, that drinking water exposures to arsenite (As+3) leads to 
immunotoxicity. Previously, our group showed that certain types of immune cells are extremely 
sensitive to arsenic induced genotoxicity. In order to see if cells from different immune organs 
have differential sensitivities to As+3, and if the sensitivities correlate with the intracellular 
concentrations of arsenic species, male C57BL/6J mice were dosed with 0, 100 and 500 ppb As+3 
via drinking water for 30 d. Oxidation State Specific Hydride Generation-Cryotrapping- 
Inductively Coupled Plasma- Mass Spectrometry (HG- CT- ICP- MS) was applied to analyze the 
intracellular arsenic species and concentrations in bone marrow, spleen and thymus cells isolated 
from the exposed mice. A dose-dependent increase in intracellular monomethylarsonous acid 
(MMA+3) was observed in both bone marrow and thymus cells, but not spleen cells. The total 
arsenic and MMA+3 levels were correlated with an increase in DNA damage in bone marrow and 
thymus cells. An in vitro treatment of 5, 50 and 500 nM As+3 and MMA+3 revealed that bone 
marrow cells are most sensitive to As+3 treatment, and MMA+3 is more genotoxic than As+3. 
These results suggest that the differential sensitivities of the three immune organs to As+3 
exposure are due to the different intracellular arsenic species and concentrations, and that MMA+3 
may play a critical role in immunotoxicity.
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1. INTRODUCTION
Arsenic (As) contamination in food and drinking water is a world-wide public health issue. 
The trivalent inorganic form of As, arsenite (As+3), is the most prevalent form in the 
environment. Exposure to As is associated with multiple diseases such as skin lesions, 
diabetes, cardiovascular diseases, and cancers (Argos et al., 2010; Schuhmacher-Wolz et al., 
2009; Vahter et al., 2008). Once As+3 gets into the body, it is metabolized into monomethyl 
and dimethyl trivalent and pentavalent species (Aposhian and Aposhian, 2006). 
Monomethylarsonous acid (MMA+3) has been shown to be more toxic than As+3 both in 
vivo and in vitro (Petrick et al., 2001; Styblo et al., 2000). MMA+3 can be further 
metabolized to dimethylarsonous acid (DMA+3) or dimethylarsinic acid (DMA+5) and 
excluded from the body.
Arsenic induced immunotoxicity has been studied by many groups both in vitro and in vivo 
(Ahmed et al., 2014; Nadeau et al., 2014; Biswas et al., 2008; Vahter et al., 2008; Soto-Peña 
et al., 2006; Gonsebatt et al., 1994). However, only a few studies have addressed the toxicity 
of As exposure to immune cells at environmentally relevant concentrations. Previous studies 
in our laboratory showed that in vivo drinking water exposure to As+3 at very low 
concentrations suppresses mouse bone marrow and spleen cell functions (Ezeh et al., 2014; 
Li et al., 2010). Human peripheral blood mononuclear cells (HPBMC) studies also showed a 
dose-dependent suppression of T cell proliferation at extremely low concentrations of As+3 
(0.1–10 nM) in some individuals, with virtually all individuals susceptible to T cell 
immunosuppression by MMA+3 (Burchiel et al., 2014). Therefore, lymphocytes are 
extremely sensitive to As+3 exposure at environmentally relevant levels. However, it is 
unclear whether immunotoxicity is likely due to As+3 or MMA+3.
T cells are generated in bone marrow and transferred to the thymus for development, while 
B cells develop in bone marrow. The spleen is a critical immune organ for the storage of 
both T and B cells and for systemic immune responses. In a previous study on the 
genotoxicity induced by As+3 in mouse thymus cells, we showed that mouse thymus cells 
are extremely sensitive to As+3 induced DNA damage, which is correlated with the 
inhibition of a base excision repair factor, Poly (ADP-ribose) polymerase (PARP) (Xu et al., 
2016b). In the present study, the sensitivities of the three immune organs, bone marrow, 
spleen and thymus to As induced genotoxicity were compared both in vivo and in vitro. The 
species and levels of intracellular arsenic contents in the cells from the three immune organs 
were also determined and compared.
2. METHODS
2.1. Chemicals and Reagents
Sodium arsenite (CAS 774-46-5, NaAsO2, Purity ≥ 90%) was purchased from Sigma-
Aldrich (St. Louis, MO). Methylarsine iodide (MMA+3) was obtained from Drs. Terry 
Monks and Todd Caminesch at the Southwest Environmental Health Sciences Center, 
University of Arizona. Penicillin/Streptomycin (Pen/Strep) and L-Glutamine were purchased 
from Life Technologies (Grand Island, NY). Dulbecco’s phosphate buffered saline w/o Ca+2 
or Mg+2 (DPBS−) was purchased from Mediatech (Manassas, VA). Dimethyl sulphoxide 
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(DMSO), RPMI 1640 and Iscove’s Modified Dulbecco’s Medium (IMDM) base medium 
were purchased from Sigma Aldrich. Fetal Bovine Serum (FBS) was purchased from 
Atlanta Biologicals (Flowery Branch, GA). Hanks Balanced Salt Solution (HBSS) was 
purchased from Lonza (Walkersville, MD). Sodium Hydroxide (NaOH) was purchased from 
EMD Chemicals Inc. (Gibbstown, NJ). 0.5 M EDTA solution was purchased from Promega 
(Madison, WI). The Comet Assay kit (Cat. No. 4252-040-ESK), hOGG1 FLARE™ Assay 
kit (Cat. No. 4130-100-FK) and the PARP activity kit (Cat. No. 4685-096-K) were 
purchased from Trevigen (Gaithersburg, MD). The BCA assay kit (Cat. No. 23225) was 
purchased from Thermo Scientific (Rockford, IL).
2.2. Mouse In Vivo Exposures
C57BL/6J male mice were purchased at 8 weeks of age from Jackson Laboratory (Bar 
Harbor, ME). All animal experiments were performed following the protocols approved by 
the Institutional Animal Use and Care Committee at the University of New Mexico Health 
Sciences Center. Following one week of acclimation, mice (2–3 per cage) were exposed to 
As+3 at different concentrations via drinking water for 30 d. As+3 doses were prepared fresh 
weekly by weighing each water bag and determining the appropriate amount of stock As+3 
solution to add to each bag to yield 100 and 500 ppb. No treatment was added to control 
bags. Water bags were weighed after each week and the change in weight was used to 
estimate the amount of water consumed by each group. The As+3 concentrations in drinking 
water were verified using Mass Spectrometry by Dr. Abdul-Mehdi S. Ali at Department of 
Earth and Planetary Sciences, University of New Mexico. Mice were fed 2020X Teklad 
global soy protein-free extruded rodent diet (Envigo, Indianapolis, IN) throughout the 
experiment.
2.3. Isolation of Bone Marrow Cells
Bone marrow cells were isolated according to the procedures described in Ezeh et al., 2014. 
Basically, mouse femurs were collected into HBSS medium in our animal facility and 
transferred to our laboratory to extract cells. Femurs were placed in petri dish containing 5 
ml of cold sterile bone marrow medium (500 ml IMDM with 2% FBS, 2 mM L-glutamine, 
and 100 mg/ml Pen/Strep) and trimmed to expose interior marrow shaft of the femur, the end 
of the femur were then cut off. one cc syringe and 25 gauge needle were used to flush the 
bone marrow medium through the femur several times to release cells into the petri dish. 
The suspension was immediately transferred to a 15 ml centrifuge tube, centrifuged at 200 
×g for 10 min, aspirated, and washed with bone marrow medium. The cell count and 
viability were determined by acridine orange/propidium iodide (AO/PI) staining on a 
Nexcelom Cellometer 2000.
2.4. Isolation of Thymus and Spleen Cells
Thymus and spleen were isolated following the sterile procedures described in Xu, et al., 
2016. Basically, mouse thymus and spleen were harvested in our animal facility and 
transferred to the laboratory in HBSS on ice. Single cell suspensions of spleen and thymus 
cells were prepared by homogenizing the organ between the frosted ends of two sterilzed 
microscope slides (Fisher Scientific, Pittsburgh, PA) into a dish containing 5 mL of cold 
mouse medium (500 ml RPMI 1640 with 10% FBS, 2 mM L-glutamine, and 100 mg/ml 
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Pen/Strep). Suspended cells were centrifuged at 200 ×g for 10 min, aspirated, and washed 
with mouse medium. The cell count and viability were determined by AO/PI staining on a 
Nexcelom Cellometer 2000.
2.5. Oxidation state specific Hydride Generation- Cryotrapping- Inductively Coupled 
Plasma-Mass Spectrometry (HG- CT- ICP- MS)
The analysis of tri- and pentavalent As species was performed by HG-CT-ICP-MS as 
previously described (Currier et al., 2014; Matousek et al., 2013). Briefly, cell pellets were 
lysed in ice-cold deionized water. The trivalent species, As3+, MMA3+, and dimethylarsinite 
(DMA3+) were measured in an aliquot of cell lysate directly, without pretreatment. Another 
aliquot was treated with 2% cysteine and analyzed for total inorganic As (As3+ + As5+), total 
methyl-As (MMA3+ + MMA5+), and total DMAs (DMA3+ + DMA5+). Calibration curves 
were generated using cysteine-treated pentavalent As standards, (at least 98% pure) as 
previously described (Hernández-Zavala et al., 2008). The concentrations of pentavalent As 
species were determined as a difference between the values obtained for cysteine-treated 
aliquots and values from untreated sample aliquots. The instrumental LODs for As species 
analyzed by HG-CT-ICP-MS ranged from 0.04 pg As for methylated arsenicals to 2.0 pg As 
for inorganic arsenicals. All values are expressed as pg of As in each arsenic species.
2.6. In Vitro As+3 and MMA+3 Treatments
Bone marrow, spleen and thymus cells were isolated as described above from three 13-week 
old male C57BL/6J mice and pooled. Cells were washed and resuspended at 1 × 106 cells/ml 
in IMDM (for bone marrow cells) or mouse medium (for spleen and thymus cells). As+3 or 
MMA+3 were added to each wells to the final concentrations of 0 (control), 5, 50 and 500 
nM. Cells were placed into a humidified 37 °C, 5% CO2 incubator for 4 h. Treated cells 
were harvested by centrifugation at 200 ×g for 10 min and resuspended in cold DPBS−. 
After another wash with cold DPBS−, the cells were ready for Comet assay analysis.
2.7. Comet Assay (Single Cell Gel Electrophoresis Assay) and Fragment Length Analysis 
using Repair Enzymes (FLARE) Assay
Treated cells were immobilized in a bed of low melting point agarose on a Trevigen 
CometSlide™ following the Comet assay kit instructions. Cells were then lysed with Lysis 
Solution with 10% DMSO (Sigma-Aldrich) over night. On the next day, DNA in the lysed 
cells were unwound with basic buffer (8 g NaOH with 500 mM EDTA in 1 L of Milli-Q 
water, pH>13) at room temperature for 45 min. For FLARE assay, human 8-oxoguanine 
DNA glycosylase 1 (hOGG1) from the FLARE kit was diluted to 1:5 and applied to the 
wells. Slides were then incubated at 37 °C for 30 min before adding the unwinding buffer. 
For both assays, slides were electrophoresed in ice cold basic buffer with 21 volts for 30 
min. Slides were washed, dried and stained with Sybr Gold (1:10000 dilution in TE buffer) 
and imaged using an epifluorescence microscope. Fifty randomly selected cells from each 
well were scored using CometScore software (TriTek Corp., Sumerduck, VA). DNA damage 
was reported by percentage of DNA in tail (Collins, 2004).
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2.8. PARP activity assay
The PARP activity assay was performed using the Trevigen PARP activity kit. All reagents 
were supplied by the kit unless otherwise specified. The procedures were previously 
described by Sun et al., 2012. Basically, cells were lysed with the Cell Extraction Buffer 
supplied in the kit, and the protein concentration was determined by the BCA Protein Assay. 
Two hundreds ng of total proteins from each sample was combined with activated DNA and 
nicotinamide adenine dinucleotide (NAD) supplied by the kit, and then placed into a 
histone-coated strip well to formed PAR complex which was fixed to the bottom of the well. 
Anti-PAR monoclonal antibody was then added to the well to bind to PAR complex, 
followed by a Horseradish peroxidase (HRP) conjugated secondary antibody against the 
primary antibody. TACS- Sapphire™ was used a substrate to generate the 
chemiluminescence signal. An equal amount of 0.2 M HCl was added to stop the reaction. 
The signals were detected using SpectraMax® 340PC microplate reader (Molecular 
Devices, Sunnyvale, CA) at 450 nm wavelength.
2.9. Statistics
Data were analyzed using Excel 2013 and Sigma Plot v12.5 software. One-way analysis of 
variance (ANOVA) and Dunnett’s t-test were used to determine differences between the 
control and treatment groups. Pearson Correlation and polynomial linear regression were 
used to analyze the correlations between intracellular As concentrations and DNA damage 
increases. All groups (Control and As+3 exposed groups) were used in the correlation 
analysis. For in vivo As+3 treatment, 5 animals (n = 5) were assigned to each treatment 
group. For the in vitro experiments, three replicates were performed and analyzed for each 
dose.
3. RESULTS
3.1. Intracellular arsenic species in the bone marrow, spleen and thymus cells of drinking 
water exposed mice
9-week old C57BL/6J male mice were exposed to 0, 100, and 500 ppb As+3 through 
drinking water for 30 d. No change in mouse body weight or water intake was observed 
during or after the exposure (Table 1). As+3 intake was calculated from the water intake of 
each mouse and the As+3 concentrations in the drinking water determined by mass 
spectrometry. Bone marrow, spleen and thymus were harvested from each mouse and the 
cells were isolated. Although not statistically significant, there was a trend of decrease in 
thymus weight, as well as the bone marrow and thymus cell recoveries (Table 1). The spleen 
weight and cell recovery were not affected by As+3 exposure. In order to measure the 
intracellular species and amounts of arsenic in these tissues from As+3 exposed mice, we 
used a very sensitive HG- CT- ICP- MS system to analyze the intracellular As levels in 5 × 
106 cells pelleted from each tissue, as well as 50 µl plasma from each mouse (Table 2). A 
dose-dependent increase in total intracellular As levels was observed in bone marrow, spleen 
and plasma but not the spleen. Control mice showed detectable levels of As, presumably due 
to small amounts of As present in food and City of Albuquerque drinking water, which has 
As levels less than 5 ppb. Interestingly, the major increased As species in bone marrow and 
thymus was the trivalent methylated form, MMA+3, which was almost undetectable in 500 
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ppb exposed spleen cells. Therefore, these results not only demonstrated that spleen is the 
least exposed tissue among the three immune organs, but also indicated that MMA+3 may be 
the major cause of genotoxicity in As+3 in vivo exposures. The concentrations of arsenic in 
plasma were an order of magnitude higher than those in cells from immune tissues; here 
DMA+3 and DMA+5 are the major metabolites.
3.2. Differential sensitivities of bone marrow, spleen and thymus in DNA damage and PARP 
activity to in vivo arsenic exposures
To compare the genotoxicity between lymphoid tissues, we performed Comet Assay on the 
cells obtained from the spleen, thymus, and bone marrow. Results showed a significant 
increase in DNA damage in both bone marrow and thymus cells starting at 100 ppb (Fig. 1A 
and 1C). No increase of DNA damage was observed in spleen cells (Fig. 1B). The activity of 
PARP was also measured as a common endpoint to see if the DNA repair ability was also 
inhibited. Arsenic is known to cause PARP inhibition, which has been shown to result in 
increased DNA damage (Qin et al., 2008; Xu et al., 2016b; Zhou et al., 2011). A dose-
dependent decrease in PARP activity was seen in bone marrow and thymus cells (Fig. 2A 
and 2C). No change in PARP activity was observed in spleen cells (Fig. 2B). These results 
showed that bone marrow and thymus cells are more prone to genotoxicity compared to 
spleen cells, which may be the result of higher intracellular As and MMA+3 concentrations 
in in vivo exposures.
3.3. Correlations between DNA damage increase and intracellular arsenic concentrations 
in bone marrow, spleen and thymus cells
In vivo exposures to As+3 resulted a dose-dependent increase in total As and MMA+3 
intracellular concentrations in bone marrow and thymus cells. We performed a regression 
analysis to reveal the relationships between total As or MMA+3 intracellular levels and the 
DNA damage in bone marrow, spleen and thymus cells. As shown, the amount of DNA 
damage correlated with the intracellular total As as well as the MMA+3 levels in bone 
marrow and thymus cells (Fig. 3A, 3C, 3D and 3F). There was no correlation between the 
DNA damage and intracellular As in the spleen cells (Fig. 3B and 3E). This analysis 
demonstrated that higher in vivo exposure to As+3 can increase the intracellular total As and 
MMA+3 in the bone marrow and thymus cells, which may induce or increase DNA damage 
in these immune tissues.
3.4. Differential sensitivities of bone marrow, spleen and thymus in DNA damage to in vitro 
arsenic exposures
In order to see if the differential sensitivities observed between spleen, thymus and bone 
marrow were due to different cell type susceptibilities, we directly added As+3 and MMA+3 
to primary cultures of these cells. Cells were isolated and treated with 5, 50 and 500 nM 
As+3 or MMA+3 in vitro for 4 h and then were assessed for DNA damage using Comet 
assay. As shown in Fig 4A, bone marrow cells were sensitive to As+3 at concentrations as 
low as 5 nM. Spleen and thymus cells were only sensitive to As+3 treatment at the high 
concentration (500 nM, Fig. 4B and 4C). However, cells from all the three organs were 
sensitive to MMA+3 starting at the 5 nM concentration, indicating that MMA+3 is more 
genotoxic than As+3 in vitro. It was also observed that bone marrow cells seemed to be the 
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most sensitive among all the three organs. However, the sensitivities of spleen and thymus 
were comparable in vitro, indicating that the lower sensitivity in spleen cells observed in the 
in vivo experiment was due to lower As accumulation. The FLARE assay is a modified type 
of Comet assay that uses hOGG1 to enhance its sensitivity to detect oxidative DNA damage 
(Smith et al., 2006). We performed the FLARE assay with same samples used for the 
Alkaline Comet assay following 4 h incubation with As+3 and MMA+3. The results obtained 
from the FLARE assay were similar to the Comet assay, except that a significant increase in 
DNA damage was observed at high doses of As+3 and MMA+3 only in thymus cells (Fig. 
4C). This observation is consistent with our previous findings that As+3 induced oxidative 
stress in thymus cells at high concentrations (Xu et al., 2016b). These results demonstrated 
that bone marrow, spleen and thymus cells are more sensitive to MMA+3 induced 
genotoxicity than As+3 in vitro, indicating that the higher sensitivities of bone marrow and 
thymus cells in in vivo exposures were likely due to the significantly increased MMA+3 
intracellular concentrations.
4. DISCUSSION
As+3 is known to cause multiple and complicated biological effects. There have been many 
studies focusing on the toxicity of As+3 over the years. However, two basic questions are 
often ignored when we set up the biological models and expose animals or cells to As+3. 
What is the actual level of exposure and what chemical species are responsible for 
immunotoxicity in various lymphoid tissues? From previous studies, we know that various 
inorganic and organic arsenic species have differential toxicities (Akter et al., 2005). From 
studies in our laboratory, we have found that cells from different immune organs and tissues 
have differential sensitivities to As (Ezeh et al., 2014, 2016; Li et al., 2010; Xu et al., 2016a, 
2016b). Therefore, it is important to determine if lymphoid organs and tissues, such as bone 
marrow, spleen and thymus have differential sensitivities to As+3 in terms of genotoxic and 
non-genotoxic actions both in vivo and in vitro.
In this study, intracellular As concentrations and species were measured in lymphoid cells 
isolated from three immune organs following As+3 30 d drinking water exposure. A 
correlation between increased DNA damage and increased intracellular MMA+3 levels was 
found in both bone marrow and thymus cells (Fig. 1 and Table 2). Spleen cells were not as 
sensitive as bone marrow and thymus cells in vivo, and the intracellular MMA+3 levels in the 
spleen were not as high as seen in bone marrow and thymus, which can be the reason that 
caused the sensitivity differences. T and B cells in the spleen are more mature than those in 
the bone marrow and thymus, which might be a factor that accounts for the differential 
intracellular As concentrations. One of our previous studies showed that the thymus cells at 
the earlier stage (double negative) are more prone to As+3 induced toxicity than the later 
stage (double positive) (Xu et al., 2016a). Therefore, it is possible that more mature cells are 
resistant to As toxicity, due to a lower intracellular As concentration or less toxic 
intracellular As species. Another observation that supports this hypothesis is that bone 
marrow cells were sensitive to even 5 nM As+3 exposure in vitro (Fig. 1A). Bone marrow 
consists of multiple types of early progenitor cells and the very early stage of pre-T cells that 
migrate to the thymus. It is important to understand potential mechanisms responsible for 
the susceptibility of early lymphoid cells to As toxicity. Also, in the Comet assay 
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experiments, we noticed that it is very common for bone marrow cells to have higher 
background DNA damage from in vivo exposures, which may also due to the fragility of the 
progenitor cells in the bone morrow.
MMA+3 has been shown to be more toxic than As+3 in lymphoid and non-lymphoid tissues. 
MMA+3 is formed in vivo mostly in the liver, kidneys, and lungs under the influence of the 
AS3MT enzyme (Chen et al., 2011). We have found little enzyme expression of AS3MT in 
mouse lymphoid tissue, and have found little evidence for metabolism of As+3 in lymphoid 
tissues (unpublished data). Thus we believe that the presence of MMA+3 in lymphoid tissues 
is a reflection of MMA+3 uptake from the blood. From Table 2, we know that although the 
pentavalent forms of As species in the plasma are MMA+5, DMA+3 and DMA+5, the 
MMA+3 concentration was also significantly increased. In Supplementary Table 1, we found 
that 500 ppb exposure of mice resulted in a 477 nM intracellular concentration of total As 
species in thymus cells, which is in the concentration range for our in vitro studies (Figure 
4). MMA+3 was the most prevalent form in high dose exposed bone marrow and thymus 
cells. Also, there was As+5 in cells from all three tissues, but As+3 was almost undetectable 
in all three tissues. Therefore, we think that the differences in bone marrow and thymus 
compared to spleen may result from a difference in the ability of cells either to import or 
export As+3 and MMA+3 or to convert MMA+5 to MMA+3. Our current efforts are aimed at 
measuring these differences.
Regarding the mechanism of DNA damage produced by MMA+3, it has been found that 
MMA+3 may produce stronger inhibition than As+3 of PARP, a zinc finger protein that is 
required for base excision repair, (Sun et al., 2012; Zhou et al., 2014). In our previous 
studies, we demonstrated a correlation between PARP activity inhibition and the increase of 
DNA damage in mouse thymus cells (Xu et al., 2016b). Therefore, the DNA damage 
increase observed in the mouse bone marrow and thymus cells following in vivo As+3 
exposure appears to result from suppression of the DNA repair system.
In summary, the present study showed differential sensitivities of the cells from three 
important immune organs, bone marrow, spleen and thymus, to As+3 induced genotoxicity in 
vivo. The in vivo sensitivity was shown to be correlated with an increase in the trivalent 
methylated arsenic species, MMA+3. Bone marrow cells were found to be the most sensitive 
tissue in vitro, which may relate to the immaturity of the various cell types. These studies 
stress the importance of measuring lymphoid tissue exposure and performing speciation 
analyses for arsenic studies.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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HIGHLIGHTS
• MMA+3 is the main species in bone marrow and thymus in As+3 
exposed mice.
• Bone marrow is the most sensitive lymphoid tissue to arsenic-induced 
genotoxicity.
• Increase in DNA damage is correlated with more intracellular MMA+3 
in bone marrow and thymus.
• An in vivo exposure to 100 ppb As+3 induced genotoxicity in bone 
marrow and thymus.
• MMA+3 is more genotoxic than As+3 in vitro.
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Figure 1. 
DNA damage in bone marrow, spleen and thymus cells from 30 d As+3 drinking water 
exposed mice. 9-week old male C57BL/6J mice were exposed to 0, 100 and 500 ppb As+3 
through drinking water for 30 d. Bone marrow, spleen and thymus cells were isolated and 
the DNA damage was measured by Comet assay. A, bone marrow. B, spleen. C, thymus. 
*Significantly different compared to control (p<0.05, n=5). Results are Means ± SD.
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Figure 2. 
PARP activity in bone marrow, spleen and thymus cells from 30 d As+3 drinking water 
exposed mice. 9-week old male C57BL/6J mice were exposed to 0, 100 and 500 ppb As+3 
through drinking water for 30 d. Bone marrow, spleen and thymus cells were isolated and 
the PARP activity assay was used to measure the PARP activity in the cell protein lysates. A, 
bone marrow. B, spleen. C, thymus. *Significantly different compared to control (p<0.05, 
n=5). Results are Means ± SD.
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Figure 3. 
Correlations between intracellular total As or MMA+3 concentrations and DNA damage in 
bone marrow, spleen and thymus cells from 30 d As+3 drinking water exposed mice. A, total 
As and DNA damage in bone marrow cells. B, total As and DNA damage in spleen cells. C, 
total As and DNA damage in thymus cells. D, MMA+3 and DNA damage in bone marrow 
cells. E, MMA+3 and DNA damage in spleen cells. F, MMA+3 and DNA damage in thymus 
cells.
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Figure 4. 
DNA damage in bone marrow, spleen and thymus cells treated with As+3 and MMA+3 in 
vitro for 4 h. Cells were isolated from three 13-week old C57BL/6J mice and pooled. Bone 
marrow, spleen and thymus cells were then treated with 5, 50 and 500 nM As+3 or MMA+3. 
Comet assay and FLARE assay were used to analyze the DNA damage and oxidative 
damage induced by the treatments. A, bone marrow. B, spleen. C, thymus. *Significantly 
different compared to control (p<0.05). #Significantly different compared to the Comet 
assay (p<0.05) Results are Means ± SD.
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Table 1
Mouse body weight, water, arsenic (As) intake, tissue weight, cell recovery and viability of 30 d 0 (Control), 
100 and 500 ppb As+3 in vivo drinking water exposed male C57/BL6 mice1.
Treatments Mouse body weight
(g)
Water intake (ml/d) As intake (ng/d)2
Control 27.71 ± 1.66 3.34 ± 0.11 18.50 ± 0.77
100 ppb 27.53 ± 2.69 3.68 ± 0.27 420. 54± 12.32*
500 ppb 27.50 ± 1.42 3.59 ± 0.34 2111.32 ± 323.19*
Tissue weight (mg) Cell recovery (× 106
cells)
Viability (%)
Bone
Marrow
Control 51.35 ± 12.75 86.16 ± 2.93
100 ppb 42.78 ± 4.82 88.64 ± 1.72
500 ppb 43.14 ± 8.12 87.46 ± 2.10
Spleen Control 106 ± 6.60 186.6 ± 13.39 77.72 ± 3.19
100 ppb 106 ± 6.04 183.4 ± 14.31 74.75 ± 1.71
500 ppb 103 ± 10.03 180.8 ± 30.96 76.32 ± 2.65
Thymus Control 52.32 ± 7.31 71.32 ± 14.50 87.16 ± 1.56
100 ppb 46.24 ± 5.73 69.62 ± 17.24 87.68 ± 1.20
500 ppb 40.88 ± 11.69 60.34 ± 16.85 87.98 ± 0.89
1
Mice were 9-week old when the exposure started. 5 mice (n = 5) were treated for each single dose. Drinking water was changed each week and 
water intake was calculated from the change in the weight of the water. Cell recovery and viability were obtained using a Cellometer 2000 with 
AO/PI staining. Results are Means ± SD.
2As intake was calculated based on drinking water samples measured by Mass Spectrometry and daily water intake of each mouse.
*Significantly different from Control (p < 0.05).
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